Covered recipient · General Payments record
TIEN-I SU
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$13,579.20
- Reported across 294 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $7,500.00 | 1 |
| Food and Beverage | $1,029.36 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $7,686.40 | 9 |
| Amgen Inc. | $192.34 | 3 |
| PFIZER INC. | $168.68 | 4 |
| Janssen Biotech, Inc. | $145.15 | 1 |
| GENZYME CORPORATION | $137.35 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.86 | 3 |
| GlaxoSmithKline, LLC. | $64.61 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.60 | 1 |
| Acerta Pharma LLC | $34.37 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $42.38 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177163 | CMS |
| ABBVIE INC. | $8.98 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177165 | CMS |
| ABBVIE INC. | $24.33 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177167 | CMS |
| ABBVIE INC. | $17.35 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177169 | CMS |
| ABBVIE INC. | $33.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177171 | CMS |
| ABBVIE INC. | $20.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177173 | CMS |
| ABBVIE INC. | $7,500.00 | 05/30/2024 | Grant | Undisputed | 01/23/2026 | 1106177175 | CMS |
| ABBVIE INC. | $15.98 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177177 | CMS |
| ABBVIE INC. | $23.92 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106177179 | CMS |
| Amgen Inc. | $22.16 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117694808 | CMS |
| Amgen Inc. | $150.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116157081 | CMS |
| Amgen Inc. | $20.18 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116157087 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.92 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104405003 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.45 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104715589 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.60 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118139954 | CMS |
| GENZYME CORPORATION | $137.35 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139796172 | CMS |
| GlaxoSmithKline, LLC. | $64.61 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116345152 | CMS |
| Janssen Biotech, Inc. | $145.15 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357377 | CMS |
| Novartis Pharmaceuticals Corporation | $19.12 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087157549 | CMS |
| Novartis Pharmaceuticals Corporation | $21.26 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087157565 | CMS |
| Novartis Pharmaceuticals Corporation | $24.48 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087157573 | CMS |
| PFIZER INC. | $25.34 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131526015 | CMS |
| PFIZER INC. | $86.84 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131568250 | CMS |
| PFIZER INC. | $23.23 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131861621 | CMS |
| PFIZER INC. | $33.27 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131419636 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.